Navigation Links
Health Canada approves cold and flu medicine

ditional?are not based on scientific evidence and products in the "monograph" category have claims which are not supported by specific research on their particular product.

“There’s no cure for the common cold,?Dr. Shan stated. “So, in medicine the traditional strategy is if you can’t treat the disease, you treat the symptoms. The COLD-fX strategy is to boost your immune system to help you avoid getting a cold or the flu in the first place, or if you do get one, to fight it more effectively."

The NHPD’s safety review confirmed the safety profile of COLD-fX with no known side effects or drug interactions for generally healthy individuals.

Health Canada established new regulations effective Jan. 1, 2004, to monitor and manage the NHP industry. CV Technologies was the first company in Canada to launch and complete a trial under the new regulations. These regulations are being phased in over a six-year period as the NHPD reviews supporting safety, efficacy and quality information for all natural health products.

Although there are grey areas between the definitions of drugs and natural health products in general, the major distinction is that natural health products are derived from natural sources. Natural health products require the same degree of scientific evidence as drugs to support their claims. Natural health product regulations are also similar to drug regulations with requirements for standardized labeling, good manufacturing practices, and specification requirements for finished products and post-market surveillance for potential adverse effects.


'"/>

Source:University of Alberta


Page: 1 2

Related biology news :

1. BioMed Central welcomes the new National Institutes of Health public access policy
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Health costs soar as 60 million Americans classed as obese
4. Going To Extremes To Improve Human Health
5. Patient-choice C-section rate rises 36%: HealthGrades study
6. Grand Challenges in Global Health initiative funds Yale project
7. Health benefits of a Christmas brandy
8. Health of coral reefs detected from orbit
9. Health of Acehnese reefs in the wake of the tsunami shows human impacts more harmful
10. Healthy coral reefs of Madagascar resisting damage from climate change
11. Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer

Post Your Comments:
(Date:12/2/2009)...ke their first cigarette within minutes after waki...oduct of nicotine when processed by the body, than... of cigarettes smoked. , "Since cotinine leve...results suggest that smokers who smoke immediately...ancer," said researcher Joshua E. Muscat, Ph.D., M...
(Date:12/2/2009)...condhand smoke for a prolonged period of time and ...ancer, even in women who never smoked cigarettes t...to side-stream smoke could increase risk of breast...nolds, Ph.D., senior research scientist at the Nor..."While no single epidemiologic study can answer th...
(Date:12/2/2009)...moky Mountain forest,s woodland herb population ha... understories recover from logging, according to P...ng in portions of the forest nearly 80 years ago, ...ry forest floor was similar to that of undisturbed...sor of forestry and natural resources, said that c...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 1NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 2NATB Announces Partnership With Ronald McDonald House Charities 28R 29 53932 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 1Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 2Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 13443 4
... This release is available in French . , Cana...ed a DNA sequence that controls the variability of...ally significant discovery because high blood gluc...ndications of heart disease and higher mortality r...nline version of the journal Science. , The rese...
... The May 2008 issue of the Journal of the American...ch studies you may find of interest. Below is a su...formation or to receive a copy of a Journal articl...Following MyPyramid Advice, Prefer Foods High in F...he most nutrient-dense forms of the basic food gro...
... COLLEGE STATION Male seahorses are natures real-...level: Pregnancy. , Although it is common for ma...pregnancy is a complex process unique to the fish ...orses and sea dragons. Texas A&M University evolut...s in his lab are studying the effects of male preg...
Other Biology News:Genetic breakthrough explains dangerously high blood glucose levels 2Genetic breakthrough explains dangerously high blood glucose levels 3Highlights from the May 2008 Journal of the American Dietetic Association 2Highlights from the May 2008 Journal of the American Dietetic Association 3Male seahorses are nature's Mr. Mom, Texas A&M researchers say 2Male seahorses are nature's Mr. Mom, Texas A&M researchers say 3Male seahorses are nature's Mr. Mom, Texas A&M researchers say 4
(Date:12/4/2009)...if., Dec. 4 BlueFire Eth...pany focused on changing the world,s transportatio...from non-food cellulosic wastes, has been ranked n...Hottest Companies in Bioenergy;" the company,s sec... voters rank BlueFire Ethanol among the top 20 bio...
(Date:12/3/2009)... Dec. 3 ACCESS PHARMAC...ay provided an update on its European commercial l...l mucositis, a debilitating side effect of radiati...lly launched by Access, partner, SpePharm, in six ...ly, Norway, Greece and Sweden. Access is conductin...
(Date:12/3/2009)...alif., Dec. 3 Peregrine ...nced that it will release its financial results fo...er 10, 2009 at 7:00 a.m. EST and will host a confe...1:30 a.m. EST on the same day. ,, Peregrine,s s...r the second quarter ended October 31, 2009 and wi...
(Date:12/3/2009)...EW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. S...Shenzhen Beike Biotechnology Co. Ltd.,( http://www...h-Risk Diabetic,Foot Care in New Delhi, India, Nov... research and regenerative medicine company. ,,...atry Association (IPA), aimed,to help podiatrists ...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...5 million in 2008 on target; Potential label ...SEATTLE, Aug. 18 Cell Therapeutics, Inc.,(CTI) (N...r the quarter,ended June 30, 2008. Total revenues ...000 for the second quarter of 2007 due primarily t...mmercial radiopharmaceutical that,CTI acquired in ...
... 15 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB , ...Deficiency Letter from The Nasdaq Stock Market,("N...y with the audit,committee composition requirement...ires XTL to maintain an audit committee comprised ... Israeli domiciled company, is required by the Isr...
...ing Record Profitability, HARBIN, China, Aug. 15 ...tus Biotech Inc. (the "Company") (OTC Bulletin Boa...er, manufacturer and marketer of a,variety of cact...ay record,second quarter results for the period en... $5.0 million, a 34.9% increase compared to $3.7 m...
Other Biology Technology:Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 2Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 3Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 4Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 5Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 6Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 7XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition 2XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition 3China Kangtai Cactus Biotech Announces Record Second Quarter Results 2China Kangtai Cactus Biotech Announces Record Second Quarter Results 3
EcoR I/Hind III End Modification Kit from Novagen
Silencer CellReady siRNA Transfection Optimization Kit from Ambion
SUPERaseIn from Ambion
...ly and negatively supercoiled DNA in presence of E...percoiling on transcription in vitro , Studying c...e degree of supercoiling of naturally occurring DN...th by only one base-pair , Increasing restriction...
Biology Products: